Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01375218
Other study ID # 041101A
Secondary ID
Status Completed
Phase Phase 4
First received June 15, 2011
Last updated January 16, 2015
Start date June 2011
Est. completion date June 2013

Study information

Verified date December 2013
Source OrthoCarolina Research Institute, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to 1) evaluate the effectiveness of the Plastizote abduction brace compared to the Pavlik harness in the treatment of developmental dysplasia of the hip (DDH) and 2) compare parent/caregiver satisfaction between the Plastizote abduction brace and the Pavlik harness. The investigators hope to learn which brace treatment is best for a definable population so the appropriate brace can be chosen initially avoiding the time, expense, and frustration of a failed technique.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group N/A to 2 Months
Eligibility Inclusion Criteria:

1. 0-2 months of age

2. Nonterratological developmental dysplasia of the hip diagnosed by physical exam and standard of care ultrasound

Exclusion Criteria:

1. Ages greater than 2 months

2. Neurological condition

3. Terratological congenital dysplasia of the hip diagnosed by physical exam and standard of care ultrasound

4. Chromosomal abnormality

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Pavlik Brace
Pavlik Brace
Plastizote Brace
Plastizote Brace

Locations

Country Name City State
United States OrthoCarolina Research Institute, OrthoCarolina, P.A. Charlotte North Carolina

Sponsors (1)

Lead Sponsor Collaborator
OrthoCarolina Research Institute, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Resolution of instability Negative Barlow and Ortolani tests as well as improvement/normalization in ultrasound measured alpha angle and femoral head coverage 3-4 week interval No
Secondary Resolution of instability Negative Barlow and Ortolani tests as well as improvement/normalization in ultrasound measured alpha angle and femoral head coverage 6 month interval No
See also
  Status Clinical Trial Phase
Recruiting NCT04117685 - Global Hip Dysplasia Registry
Completed NCT01583465 - Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty N/A
Completed NCT04292782 - Quadratus Lumborum Block for Pediatric Hip Surgery N/A